Companies: 10,795·Total market cap: $144.5T
Novartis AG

Novartis AG

NVSNYSEHealthcare● Active
$146.87
$-2.29(-1.54%)
Market Cap$280.2B
P/E Ratio
52W High$170.46
52W Low$112.34

Novartis AG(NVS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NVS · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$54.81B$51.72B$46.66B$43.46B$43.97B
Cost of Revenue$13.69B$12.83B$12.47B$11.58B$11.73B
Gross Profit$41.12B$38.90B$34.19B$31.88B$32.24B
Gross Margin %(computed)75.02%75.20%73.27%73.35%73.31%
Operating Expenses
R&D Expenses$10.74B$10.02B$11.37B$9.17B$8.64B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$24.05B$24.35B$24.42B$23.93B$22.18B
Operating Income$17.07B$14.54B$9.77B$7.95B$10.06B
Operating Margin %(computed)31.15%28.12%20.94%18.28%22.87%
Interest Income$0.37B$0.57B$0.63B$0.38B$0.07B
Interest Expense$1.19B$1.04B$0.88B$0.83B$0.91B
Income Before Tax$16.44B$13.64B$9.12B$7.18B$24.53B
Income Tax Expense$2.40B$1.70B$0.55B$1.13B$1.63B
Net Income$14.06B$11.94B$14.85B$6.96B$24.02B
Net Margin %(computed)25.64%23.09%31.83%16.00%54.63%
Per Share & EBITDA
EPS (Basic)$7.25$5.92$7.15$3.19$10.71
Wtd Avg Shares1.94B2.02B2.08B2.18B2.24B
EBITDA$22.99B$20.71B$18.25B$14.68B$30.91B
EBITDA Margin %(computed)41.94%40.05%39.12%33.78%70.30%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Novartis AG

关于Novartis AG(NVS)损益表

Novartis AG(NVS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,NVS实现营收$54.81B,毛利润$41.12B(毛利率75.02%),净利润$14.06B(净利率25.64%)。

常见问题

NVS · 4 问

Novartis AG(NVS)2025财年营收为$54.81B,同比up6.0%。

NVS revenueNVS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08